Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation. by Rohrbach, M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/96195
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
RESEARCH Open Access
Phenotypic variability of the kyphoscoliotic type
of Ehlers-Danlos syndrome (EDS VIA): clinical,
molecular and biochemical delineation
Marianne Rohrbach1,2*, Anthony Vandersteen3, Uluç Yiş4, Gul Serdaroglu5, Esra Ataman6, Maya Chopra7,
Sixto Garcia8, Kristi Jones7, Ariana Kariminejad9, Marius Kraenzlin10, Carlo Marcelis11, Matthias Baumgartner1 and
Cecilia Giunta1,2
Abstract
Background: The kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA) (OMIM 225400) is a rare inheritable
connective tissue disorder characterized by a deficiency of collagen lysyl hydroxylase 1 (LH1; EC 1.14.11.4) due to
mutations in PLOD1. Biochemically this results in underhydroxylation of collagen lysyl residues and, hence, an
abnormal pattern of lysyl pyridinoline (LP) and hydroxylysyl pyridinoline (HP) crosslinks excreted in the urine.
Clinically the disorder is characterized by hypotonia and kyphoscoliosis at birth, joint hypermobility, and skin
hyperelasticity and fragility. Severe hypotonia usually leads to delay in gross motor development, whereas
cognitive development is reported to be normal.
Methods: We describe the clinical, biochemical and molecular characterisation, as well as electron microscopy
findings of skin, in 15 patients newly diagnosed with this rare type of Ehlers-Danlos syndrome.
Results: Age at diagnosis ranged from 5 months to 27 years, with only 1/3 of the patients been diagnosed
correctly in the first year of life. A similar disease frequency was found in females and males, however a broad
disease severity spectrum (intra- and interfamilial), independent of molecular background or biochemical
phenotype, was observed. Kyphoscoliosis, one of the main clinical features was not present at birth in 4 patients.
Importantly we also noted the occurrence of vascular rupture antenatally and postnatally, as well as developmental
delay in 5 patients.
Conclusion: In view of these findings we propose that EDS VIA is a highly variable clinical entity, presenting with a
broad clinical spectrum, which may also be associated with cognitive delay and an increased risk for vascular
events. Genotype/phenotype association studies and additional molecular investigations in more extended EDS VIA
populations will be necessary to further elucidate the cause of the variability of the disease severity.
Background
The kyphoscoliotic type of Ehlers-Danlos syndrome
(EDS), type VIA (MIM 225400) is a rare autosomal
recessively inherited connective tissue disorder with a
disease incidence of approximately 1;100,000 live births.
The disorder is characterized at birth by severe muscu-
lar hypotonia often requiring invasive neuromuscular
work-up, kyphoscoliosis which is progressive and severe,
marked joint hypermobility and luxations, and severe
skin hyperelasticity. In addition, there is fragility of the
skin with abnormal scarring, osteopenia without ten-
dency to fractures, often a striking Marfanoid habitus
and microcornea, bluish sclera, and occasionally rupture
of arteries and the eye globe, in contrast to rupture of
the cornea reported in brittle cornea syndrome [1-3].
Intellect is reportedly unaffected.
The kyphoscoliotic type of EDS was the first inborn
error of human collagen metabolism to be defined at
the biochemical level as early as 1972, based on a family
study in which two sisters had severe progressive
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scoliosis since early infancy, marked joint laxity and
recurrent joint dislocations [4,5]. It is caused by a defi-
ciency of the collagen-modifying enzyme procollagen-
lysine, 2-oxoglutarate 5-dioxygenase 1 (LH1; EC
1.14.11.4; MIM 153454; PLOD1 or lysyl hydroxylase 1)
[4] due to homozygosity or compound heterozygosity
for a mutant PLOD1 allele(s) [1,6]
This enzyme plays an important role as a post-transla-
tional modifying enzyme in collagen biosynthesis
through both hydroxylation of lysyl residues in -Xaa-
Lys-Gly- collagen sequences to hydroxylysyl residues
which serve as sites of attachment for carbohydrate
units (either galactose or glucosyl-galactose) and in the
formation of intra- and intermolecular collagen cross-
links [7]. Thus, lysyl hydroxylase deficiency results in
underhydroxylation of lysyl residues and underglycosyla-
tion of hydroxylysyl residues in collagens and, hence,
impaired cross-link formation with consequent mechani-
cal instability of the affected tissues. However, the
underlying pathogenetic mechanism is not yet fully
understood.
As a result of underhydroxylation and underglycosyla-
tion, the collagen a-chains display a faster electrophore-
tic mobility on sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE), which in turn is used
as a diagnostic test [8].
Furthermore, the enzyme deficiency gives rise to an
abnormal urinary excretion pattern of lysyl-pyridinolines
(LP) and hydroxylysyl-pyridinolines (HP) cross-links.
The ratio of urinary total LP to HP in patients with EDS
type VIA is high as compared with normal controls [9]
and is diagnostic for EDS type VIA [6,10,11]. The diag-
nosis of EDS type VIA may then be confirmed by mea-
suring the activity of the enzyme in cultured skin
fibroblasts [12] and/or directly by mutation analysis of
PLOD1 (MIM 153454). More than 30 different muta-
tions in PLOD1 have been described in the kyhposcolio-
tic form of EDS [13-15]; among them an 8.9-kb
duplication of seven exons (exon 10-16) is the most
common cause of the disorder.
The kyphoscoliotic type of EDS has some overlapping
clinical features with other forms of EDS as well as with
a new recessive entity, with fleshy swelling of facial tis-
sues, severe scoliosis and ocular fragility, RIN2 syn-
drome [16]. Diagnosis is usually delayed because a
neuromuscular disease is suspected due to the severe
neonatal hypotonia and delay in gross motor develop-
ment. It is only after negative neuromuscular workup
that in most cases EDS VIA is suspected.
Intra- and interfamiliar variability of clinical severity
has been observed in individuals with the kyphoscoliotic
form of EDS [2,13], however no relationship between
position or type of mutation in the PLOD1 gene and the
severity of the clinical phenotype was observed so far.
Over a period of 1.5 years, 12 new index patients and
3 relatives were diagnosed with this relatively rare type
of Ehlers Danlos syndrome at our Institution. Here we
present results on individual clinical presentation, and
highlight clinical features that are striking for the diag-
nosis of EDS VIA, but also focus on rare and therefore
often underestimated complications including artery
rupture and developmental delay. In addition, we corre-
late the clinical picture with biochemical and molecular
results. Thus this paper gives an overview on clinical
symptoms, describes the broad phenotypic spectrum of
the kyphoscoliotic type of EDS, and highlights the speci-
ficity of non invasive urinary analysis of pyridinolines
which is a fast and cost effective diagnostic test for the
kyphoscoliotic form of EDS.
Methods and Materials
Clinical information
Clinical information was obtained through a question-
naire that was sent to each involved centre and subse-
quently analysed centrally. Clinical examination was in
most cases performed by a geneticist or a paediatrician.
Diagnosis of EDS VIA was based on clinical grounds in
all index patients and proven by the abnormal urinary
ratios of total pyridinolines, as shown to be diagnostic
for EDS VIA [2,10,11]. Mutation analysis of PLOD1 was
done in all but two (P8 and P11) patients, for whom
DNA was not available. For all studies informed consent
of the patients or their parents, in accordance with
requirements of the Local Ethics Committees of the
referring physicians was obtained.
Biochemical analyses and electron microscopy
Total urinary pyridinolines were measured as described
[9,11] and were expressed as the ratio of lysyl pyridino-
line (LP) to hydroxylysyl pyridinoline (HP).
Dermal fibroblast cultures were established from skin
biopsies from 4 patients (P1, P2, P7a, P10) by routine
procedures. Cells were maintained under standard con-
ditions, and radiolabelled collagen samples were pre-
pared by digestion with pepsin, precipitated with
ethanol, separated on a 5% SDS- polyacrylamide gel, and
visualized by fluorography [17]. For electron microscopy
skin biopsies were processed for transmission electron
microscopy as reported [18].
Mutation analysis
gDNA was isolated from peripheral blood leukocytes or
cultured fibroblasts using standard techniques. Each sin-
gle exon of PLOD1 was amplified by PCR using 5’ and
3’ primers designed on the flanking intron sequences as
described [13].
Mutation analysis by sequencing was performed using
the Big-Dye Terminator cycle sequencing ready-reaction
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kit version 1.1 (Life Technologies, Applied Biosystems)
and an AB 3130 Genetic Analyzer (Life Technologies,
Applied Biosystems), as described [13].
Results
Clinical features
The available clinical data of all index patients and rela-
tives (siblings/cousin) are summarized in Table 1. All
index patients, suspected with EDS VIA based on clini-
cal findings, were referred to our centre for biochemical
workup of EDS VIA, respectively urinary pyridinolines
as well as molecular analysis. Mean age at diagnosis was
6.3 years (range 5 month - 27 years), with 53% male and
47% female patients. 2/3 of all index patients were diag-
nosed before 5 years of age, 4 out of 8 patients in the
first year of life. One patient was diagnosed in adulthood
with no clinical suspicion for a connective tissue disor-
der. Most patients were reported to be a product of
consanguineous parents; 75% of the patients originating
from Turkey, former Yugoslavia and the Middle East,
while the remaining originated from Western Europe
and Somalia.
Except for P2, who had a surprisingly mild phenotype,
the patients were all noted to have with severe neonatal
muscular hypotonia and were described as floppy babies,
with a poor cry and difficulty in sucking. A neuromus-
cular disorder was suspected with subsequent invasive
muscular work-up in 7 patients (P1, P2, P5, P7a, P8,
P10, P11), including CK, electromyography, ultrasound
of muscle, and brain computer tomography or magnetic
resonance imaging (MRI); all results were normal.
Kyphoscoliosis was one of the main features presenting
at birth and was severe and progressive in up to 80%.
P10 developed kyphoscoliosis only at the age of 10 years
and P7c at the age of 20 months. All patients presented
with joint hypermobility, and some had luxations of the
hip joints at birth or later in life (P1, P3, P5, P8, and
P12). The skin was smooth and hyperelastic in all, how-
ever easy bruising with poor wound healing and
atrophic scars were noted only in P2 and P3.
Antenatal/neonatal brain haemorrhages was documen-
ted in P12 and rupture of coronary arteries in one
patient (P2). 4/12 patients diagnosed with EDSVIA with
negative neurological workup had delay of cognitive
development.
Detailed history of selected patients
P2
A 27 year old man was the 2nd child of apparently non-
consanguineous parents, which were born and raised
within 5 km distance. There is only limited information
available about his childhood; however the patient’s
father did not recall any significant differences regarding
the motor and cognitive milestones. His skin was
reported to be smooth with history of easy bruising.
The patient complained about abnormal, delayed wound
healing resulting in hypertrophic scars. His general
health however was normal, and he was full time work-
ing as a constructor. It was at the age of 27 years when
he and a co-worker both presented at the emergency
ward with nausea, dyspnoe and retrosternal pain. CO2
intoxication was suspected. After 24 hours hospitalisa-
tion he deteriorated rapidly with tachycardia and ejec-
tion fraction of only 50%. Subsequently a coronary
angiography was performed to elucidate the cause of his
cardiopathy. During the coronary angiography he had
spontaneous dissection of the ramus interventricularis
anterior (RIVA) and main coronary artery causing acute
cardiac failure. The patient’s older brother died at the
age of 20 years after an accidental fall from a balcony
(1.5 m height); he apparently suffered from arterial
bleedings that could not be managed.
P6
She is the first child of healthy Dutch parents with no
known consanguinity. She was born after an uneventful
pregnancy at 41 weeks of gestation by caesarean section
because of breech presentation. Mild oligohydramnios
was noted. Birthweight was 3.7 kg and length 55 cm (>
P97). At birth severe hypotonia with an abnormal posi-
tion of hands and contractures of both feet, as well as
velvety skin were noted. There was a mild kyphoscolio-
sis and hypermobility of the joints. At 5 months of age
she presented with significant motor delay, which
improved with physiotherapy. At the same time she pre-
sented with axial and peripheral hypotonia as well as
severe hypermobility of the joints. Growth was at the
97th percentile. She showed mild dysmorphic features
with hypotelorism, narrow palpebral fissures and an
open mouth. Her palate was high and narrow. She had
kyphoscoliosis and a pectus excavatum. At age 23
months she was able to stand unsupported and walk
with, but not without, support. Mental development and
speech development was normal.
P7a-7c
Patient 7a is the first child of consanguineous Somali
parents. Antenatally there were concerns about poor
fetal growth, along with oligohydramnios and reduced
fetal movements. She was born at 38 weeks of gestation;
birthweight was 2.8 kg (25th percentile). She was noted
with muscular hypotonia and contractures of the hands
and feet. When evaluated by paediatric neurologists, his-
tory of delayed gross motor milestones was noted and a
possible diagnosis of a congenital myopathy was consid-
ered. Open muscle biopsy (left thigh) showed variable
fibre size with mild fibrosis. Immunohistochemistry for
dystrophin, merosin, sarcoglycan and collagen VI were
reported as normal, with normal respiratory chain
enzyme studies. Assessment in the genetic clinic at 16
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Table 1 Clinical, molecular and biochemical characterization of 15 new EDS VIA patients.
P1 P2 P3 P4a P4b P5 P6 P7a P7b P7c P8 P9 P10 P11 P12
Sex M M F M M M F F F M M M F F F
Age at diagnosis 9 m 27 y 14 y 4 y 6 m 9 y 5 m 15 m 14 m 13 m 19 m 16 y 16 y 18 m 8 m
Ethnicity Mazedonia Serbia Iran Turkey Turkey Turkey Netherland Somalia Somalia Somalia Turkey Turkey Spain Turkey Iraqui
Consanguinity + - + + + + - + + + + + + + +
Urinary LP/HP # 8.16 5.47 5.59 4.02 9.5 5.15 8.48 8.32 9.03 not
done
6.98 6.1 6.51 6.6 7.8
PLOD1 mutation Dup/Dup p.L85P/p.
L85P *
c.1471-1 G
> A/
c.1471-1 G
> A*
Dup/
Dup
Dup/
Dup
c.1095C
> T/
c.1095C
> T*
c.1651-2 A
> G/
c.1651-2 A
> G*
p.G678R/p.
G678R
p.
G678R/
p.
G678R
p.
G678R/
p.
G678R
DNA not
available
p.
Q345X/
p.
Q345X*
c.466+ 1G
> A/
c.466+ 1G
> A*
DNA not
available
p.
Trp419leufsX48*/
p.
Trp419leufsX48*
muscular hypotonia at
birth
+ - + + + + + + + + + + + + +
Kyphoscoliosis at birth + - + + + + + + - - + + - + +
Marfanoid habitus + + + + + + + + + - - + - - +
Delayed gross motor
development
+ - + + + + + + + + + + + + +
delayed cognitive
development
- - - - - - - - - - + + + + +
Rupture of artery - + - - - - - - - - - - - - +
Smooth velvety skin + + + + + + + + + + + + + + +
Extensibel fragile
skin
- - + ? ? + + ? + + + ? + ? +
Joint laxity + + + + + + ? + + + + + + + +
Hip dislocation at birth + - + - - + - - - - + - - - +
Neuromuscular
workup
+ - - - - + - + - - + - + + -
Independent walking
at age
2 y 1.5 y 4 y ? ? ? 2 y n.a. ° 2 y n.a n.a 2 y ° °
*newly described
mutation
+, Finding present; -, finding absent; ? no information available,; °, patient < 24 months at last exam; n.a, not able to; m, month and y, year and # LP/HP in normal control: 0.20 ± 0.05 (range 0.10-0.38); *, newly
described mutation; §, common duplication of exon 10 to exon 16.
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months of age noted that the patient was unable to walk
independently, and required a spinal brace and leg
splints. Poor weight gain was reported in infancy due to
gastro-oesophageal reflux. There were no concerns
about cognitive development, hearing or vision. There
was marked joint laxity in all joints with soft skin tex-
ture and blue sclera. She had severe and progressive
scoliosis; placement of posterior spinal rods was neces-
sary at the age of 3 years. Due to an infectious compli-
cations rods had to be removed, subsequently her
scoliosis was measured > 100 degrees. There were no
known cardiac complications.
Patient 7b was born at 38 weeks of gestation with a
birth weight of 2.5 kg (9th-25th percentiles). There were
no abnormal findings antenatally. At 6 weeks of age she
was noted to be hypotonic with joint laxity, long and
thin fingers, soft skin and subcutaneous bruising.
Ophthalmological review at 6 months of age showed
normal visual acuity, with no evidence of myopia. There
were no known cardiac complications.
Patient 7c is the fifth child and was born at term
with a birth weight of 3.1 kg (25th percentile). She is
the cousin of P7a and P7b. She was noted with mus-
cular hypotonia at birth; karyotype, baseline metabolic
investigations and MRI brain scan were reported to
be normal. Paediatric neurology review noted gross
motor delay with no evidence of visual, auditory or
cognitive impairment. Connective tissue abnormalities
included generalised joint laxity, soft hyperextensible
skin and long and thin fingers. Cardiac review and
echocardiogram were normal. Ophthalmology noted
bilateral myopia (-3 Dioptres) with no structural
abnormalities. Orthopaedic review at 23 months
noted a slight kyphosis not regarded as requiring any
intervention.
P8
She is the first child, born at term after uneventful preg-
nancy to consanguineous (first degree cousins) parents.
Her weight and height were at 10th percentile, while her
head circumference was at 50th percentile. She was
noted at birth with severe muscular hypotonia and
kyphoscoliosis as well as smooth, hyperelastic and fragile
skin. On both hands and feet she presented flexible fin-
gers and toes and joint hypermobility. She had some
dysmorphic features such as low-set ears, broad nasal
bridge, frontal bossing, short philtrum and short neck.
At the age of 2 years she presented with motor and
metal developmental delay, and was not yet able to walk
independently. Brain MRI was normal.
P9
This is the second child to 1.5 degrees cousins, born at
term after an uneventful pregnancy. His birth weight
was 2.8 kg, height was not recorded. At the age of 6
months, hydrocephalus was detected and subsequently
treated with craniocervical surgery. Already at that point
of time he showed delayed developmental milestones,
but it was only at the age of 13 years that he was
referred for evaluation of mental and motor delay as
well as skeletal deformity. He has never walked. Physical
examination revealed that his percentiles were within
the normal range. He was noted to have strabismus,
asymmetric face, minimal prognathism, pectus excava-
tum, scoliosis, 2nd-3rd toes syndactyly on feet bilater-
ally, generalized hypotonia, joint laxity, and mental
retardation. Skeletal X-ray showed severe scoliosis and
hip dysplasia. Cranial MRI showed mild hydrocephalus
(operated). Karyotype was normal. Family history
revealed a sibling with similar clinical findings who died
at the age of 17 years from complications of a sudden
internal hemorrhage (DD: aortic aneurysm). He had
severe skeletal deformities including kyphosis and joint
laxity and soft skin; and developmental delay. There was
no autopsy performed.
P10
She is the first of four children born to healthy consan-
guineous parents (uncle-niece union) after an uneventful
pregnancy. Delivery was normal. No kyphoscoliosis or
deformities were noted at birth. In the neonatal period
she was noted to be slightly hypotonic, however her
growth and development were normal in the first year
of life. At the age of 2 years a speech delay was first
noted, and subsequently a more global delay became
apparent at the Nursery. An extended neurological
workup including metabolic screen, chromosomes, and
brain CT did not reveal an underlying cause for her
delay. Physical examination was unremarkable. At the
age of 6 years she developed epileptic seizures; brain
MRI showed non-specific white matter changes. She
was started on valproic acid with good response to
treatment. The epileptic activity on initial EEG could
not be confirmed on follow up EEG. Scoliosis was first
noted at the age of 10 years with little progression over
the following years. She has mild-moderate delay and
attends a Special Needs School. Due to her body habitus
Marfan syndrome was recently suspected. Echocardio-
graphy showed a mild mitral regurgitation with a nor-
mal aortic root diameter. She showed marked joint
laxity (Beighton score: 8/9), skin hyperelasticity with
smooth velvety and doughy feel to it, and atrophic scars
on both knees and back. She had a mild chest deformity
with asymmetry and pectus carinatum and moderate
scoliosis with slender arms and legs accompanied by
arachnodactyly. Her facial features were slightly dys-
morphic. She had a high arched palate and dental
crowding. Repeat MRI at the age of 16 years showed
subtle and non-specific linear white matter changes on
the right parietal region, with no evidence of heteroto-
pias or any other structural anomaly.
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P12
This is the third child of consanguineous (double first
cousin) parents. The pregnancy was complicated with
gestational diabetes and detection of hydrocephalus at
34 weeks of gestation. There was spontaneous onset of
labour at 38 weeks and she was born with Apgar scores
of 9 and 9 at 1 and 5 minutes, respectively, and a birth
weight of 2.8 kg (25th percentile). Congenital kyphosis
was noted. Postnatal cerebral MRI confirmed hydroce-
phalus which was presumed to be secondary to multiple
extensive intraventicular and intraparenchymal haemor-
rhages. Thrombotic screen was normal. Since then there
has been a history of developmental delay, marked
hypotonia, and failure to thrive. At 4.5 month of age her
weight was 4.5 kg (< 3rd percentile), her height was 60
cm (25 percentile) and the head circumference was 38
cm (< 3rd percentile). There was minimal subcutaneous
tissue and fat stores. Dolicocephaly, a prominent meto-
pic suture and a ridged sagittal suture, and a myopathic
facies with retrognathia were noted, as well as a left
convergent strabismus, telecanthus and epicanthic eye
folds. Her palate was very high and narrow. She had a
marked kyphosis, arachnodactyly with hypermobile
digits and soft smooth skin. There was peripheral hypo-
tonia, with a striking lack of spontaneous hand move-
ment and her wrists were held in a ‘wrist drop’ position.
Knee jerks were increased and plantar responses were
down going. She did smile and make eye contact with
her mother at age 4.5 months but there was little devel-
opmental progress at the follow up visit at age 8.5
months. Transferrin isoforms, repeat CK, karyotype and
chromosomal microarray were normal. Nerve conduc-
tion studies were also normal.
Biochemical analyses
The urinary ratios of total pyridinolines (LP to HP) were
markedly increased in all patients (mean 7.03 range 4.0 -
9.5), as compared to those of control samples (0.20 ±
0.05, range 0.10-0.38). These findings were consistent
with the diagnosis of Ehlers-Danlos syndrome, kyphos-
coliotic type (EDS VI; LP/HP 5.99 ± 0.99; range 4.30-
8.10; n = 17). LP to HP ratio was significantly higher in
the group 0-4 years, compared to the age group of 4
years and older (p = 0.02)
Collagen biochemical analysis was performed in P1, P2,
P7a and P10, only. The electrophoretic migration of the
a-chains of collagen types I, III, and V and their precur-
sors and cross-linked products synthesized by cultured
dermal fibroblasts, was increased in all patients upon
SDS-PAGE (see Figure 6 in Jarisch et al., 1998, for a simi-
lar example), and demonstrates indirectly that lysyl resi-
dues are underhydroxylated and underglycosylated [2].
Electron microscopy of skin was performed on
patients 1 and 2 and showed identical abnormalities
(Figure 1) including, variable diameters and abnormal
contours of the collagen fibrils when compared to nor-
mal controls. Diameters of the collagen fibrils were sig-
nificantly increased with loss of the normal circular
shape. In particular those fibrils with abnormally
increased diameters showed a greater deviation from cir-
cular shape (Figure 1). The elastic fibers presented nor-
mal ultrastructural features.
Molecular Analysis
Results of mutation analysis of PLOD1 performed on
genomic DNA of the patients [13] are reported in Table 1.
13 patients had molecular testing of PLOD1. All were
confirmed to carry homozygous mutations (Table 1). In
3/13 the 8.9-kb duplication of seven exons (exon 10-16)
was identified. In 7 patients previously unreported
mutations were found including 4 mutations expected
to affect splicing. Due to the unavailability of RNA, the
mutations localized at 5’ and 3’ splice donor and accep-
tor sites, respectively, were analysed in silico for the pre-
diction of aberrant splicing using NetGene2 Server
available at http://www.cbs.dtu.dk/services/NetGene2
[19]; furthermore, the effects of missense mutations on
aberrant splicing was evaluated in silico using the ESE-
finder software available at http://rulai.cshl.edu/cgi-bin/
tools/ESE3/esefinder.cgi[20,21]. 1) The c.466+1G > A at
the donor splice site of exon 4, is predicted to cause
skipping of exon 4. 2) The c.1095C > T transition in
exon 10 is expected to activate a cryptic splice site
within exon 10 which would promote aberrant splicing,
shift of the open reading frame and premature stop at
codon 386. 3) The G > A substitution at position -1 of
the 3’ acceptor splice site of exon 14 (c.1471-1 G > A) is
expected to cause the activation of a cryptic splice site
within exon 14, causing an out of frame deletion of the
first 55 bp of exon 14 leading to a premature stop in
exon 17. 4) The c.1651-2 A > G mutation at the 3’
a b
Figure 1 Electron microscopic findings of the skin of patient
P1 (a) and P2 (b) compared with normal control (middle).
Collagen fibrils are of variable diameters and are irregularly spaced.
The contour is variable from round in small fibrils to jagged in large
fibrils (arrow).
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acceptor site of exon 16, is expected to affect splicing of
exon 16, leading to skipping of exon 16.
Discussion
The kyphoscoliotic type of the Ehlers-Danlos syndrome
(EDS type VIA) is a rare autosomal recessive connective
tissue disorder, which in the first years of life mainly
affects the musculoskeletal system. Infants affected with
EDS type VIA present with moderate to severe generalized
muscle hypotonia, and with skeletal findings such as
kyphoscoliosis and joint hyperextensibility which are also
common to neuromuscular disorders such as congenital
myopathies including Bethlem myopathy and Ullrich mus-
cular dystrophy [22] as well as lower motor neuron dis-
eases, especially when deformities of the feet and joint
dislocations coexist. In all patients documented in the lit-
erature [2,11] kyphoscoliosis is usually present at birth,
and hypotonia in conjunction with the inability to stabilize
the joints, due to laxity of the connective tissue, leads to a
delay in gross motor development in the first years of life.
The kyphoscoliotic form of EDS can be diagnosed by non
invasive biochemical analysis of urinary pyridinolines;
molecular analysis of the PLOD1 gene can be added for
future prenatal diagnosis. Variability of the clinical pheno-
type is suspected even though limited data is available
about the spectrum of the disease severity; in particular lit-
tle data is available about the presentation in adulthood.
Thus, here we report on the broad clinical spectrum
found in 12 index patient and 3 relatives diagnosed
between the age of 7 months and 27 years in order to
emphasize the clinical features that add insight into the
clinical variability of the disease. Furthermore, we focus on
biochemical and molecular aspects, as well as electron
microscopy findings of relevance for a timely diagnosis.
The newborns with available history and biochemically
confirmed EDS type VIA are generally described with
hypotonia and delay of motor development in the first
few years of life [22]. All but one index case (P2) pre-
sented with significant muscular hypotonia that was
noted at birth. This patient was first diagnosed at the
age of 27 years and his family was not aware of any pro-
blems within his first few years of life. We can not
exclude however, that this clinical feature was present
but further ignored, as it is generally believed that
motor development and muscular hypotonia presenting
in the neonatal period improve over the course of time
even though kyphoscoliosis is usually progressive.
Currently, very little is known about long-term out-
come of ambulation in patients with EDS VIA, there-
fore, we present here for the first time data about the
ability of walking in a collective of 15 patients. Notably,
one patient was wheel chair bound and never able to
walk and two were reported to walk with assistance
only. It might be speculated that the absence of neonatal
kyphoscoliosis is a positive prognostic factor regarding
future ambulation, since all our patients without
kyphoscoliosis at birth were able to walk. However, in
the light of the small number of affected individuals this
assumption might be taken with caution. Based on the
results of 3 related individuals from consanguineous
parents who shared the mutant PLOD1 genotype, but
did not develop the same severity and age of onset of
kyphoscoliosis, we conclude that this clinical feature
might not correlate with the genotype.
A feature that was present in all patients was smooth
velvety skin; it should therefore be included to the speci-
fic diseases features/characteristics. In particular, velvety
skin texture may help to distinguish EDS, kyphoscolitic
form from congenital myopathies.
Kyphoscoliosisis, attributed to muscular hypotonia
together with ligamentous laxity, is generally also
reported at birth and represents one of the striking hall-
marks of this disease; it should prompt clinician to the
diagnosis of EDS type VIA as it is usually not found in
neuromuscular diseases. Surprisingly, kyphoscoliosis at
birth was not reported in 4 of our patients.
However, two of them developed kyphoscoliosis later
in life (Table 1), while P2 did not develop any asymme-
try of the spine until the age of 27 years. Interestingly,
this patient did not present with hypotonia in childhood,
in contrast to the other two, suggesting that lack of
hypotonia at birth might be a favorable prognostic find-
ing for non developing spine deformity later in life.
Indeed, data from PLOD1-/- mice suggest a direct corre-
lation between lack of kyphosis and absence of muscle
hypotonia at birth [23].
In addition, no association between the presence of
kyphoscoliosis at birth and the type of PLOD1 mutation
was found in our collective of EDS VIA.
A lack of association between genotype and phenotype
has recently been suspected [2,13] and our findings
reflect again the phenomenon of interfamilial and intra-
familial variability of this disorder. The list of disorders
where the same mutation presents with a different phe-
notype is steadily increasing and includes, for example,
mutations of COLA1 in osteogenesis imperfecta. Modi-
fying sequence variants within the entire genome, epige-
netic factors or environmental factors may be
responsible for this observation.
In contrast to other EDS forms such as EDS type VII
[24], hip dislocations at birth seems to be a less com-
mon feature, described in only 25% of our patients.
Importantly and adding to the current knowledge of
EDS VIA, we noted the occurrence of vascular rupture
both, antenatally in one patient (P12) as well as in adult-
hood as the first clinical symptom (P2). Vascular rupture
is by far the major life-threatening complication in this
disorder however it is thought to be less frequent than
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in EDS type IV. Antenatal vascular event was previously
reported in two patients with EDS VIA, only [13]. The
finding of antenatal vascular events in our EDS VIA col-
lective increases the likelihood of their direct association
with EDS VIA. Furthermore, vascular events might be
more frequent in EDS VIA than expected. Notably, 15%
of PLOD1-/- mice died at the age of 1-4 months due to
aortic dissections, caused most likely by degenerated
smooth muscle cells and abnormal collagen fibrils of
aortic wall [23]. Thus antenatal vascular events of
unknown aetiology should therefore prompt investiga-
tions for EDS type VIA, Historically, intellect is reported
to be unaffected in kyphoscoliotic type of EDS. Unex-
pectedly, we found delayed cognitive function in 5 out
of 12 index patients, however, except for the patient
with antenatal central nervous system vascular event,
brain imaging and neurological exam did not reveal an
underlying cause for the developmental delay. Whether
the impaired cognition is in direct association with EDS
VIA or independent and therefore not part of the dis-
ease remains to be further investigated. Further, in the
context of consanguinity a concomitant disorder must
be taken into consideration.
Kyphoscoliotic type of EDS is diagnosed by abnor-
mally elevated ratio of urinary lysyl pyridinolines to
hydroxylysyl pyridinoline crosslinks and can be con-
firmed by mutation analysis of PLOD1. Our results on
LP/HP ratios indicate that the ratio is highest in the age
group 0-4 year and subsequently decreases, however
remains significantly elevated when compared to normal
controls. No correlation between LP/HP ratios and gen-
otype were observed. In all but 2 patients molecular
analysis of PLOD1 was performed confirming the diag-
nosis based on pyridinoline ratios in urine (Table 1).
Specific abnormal collagen electron microscopy findings
in skin biopsies have been described for classical EDS [18],
EDS VII [25] and recently also for RIN2-deficient patients
[16]. Here we describe typical collagen fibril alterations in
skin biopsies of two EDS VIA patients. Abnormal electron
microscopy findings (Figure 1) included variable diameters
of the collagen fibrils, irregular interfibrillar space in addi-
tion to irregular ragged outlines in cross sections. To our
knowledge these findings are distinct and have not been
described in other subtypes of EDS or other connective
tissue disorders. Furthermore, they resemble those
described in PLOD1-/- mice [23].
In summary we present 15 additional individuals with
kyphoscoliotic type of EDS. In all but one (sibling of an
index case), the diagnosis was made on clinical grounds
and subsequently confirmed by analysis of pyridinolines
in urine, as well as molecular studies of PLOD1. Deter-
mination of urinary pyridinoline cross-links is a fast,
non-invasive, simple, and indeed reliable diagnostic test
for EDS type VI.
Typical clinical features included muscular hypotonia
at birth and smooth velvety skin. However adding to the
current knowledge, kyphoscoliosis was not necessary
present at birth/diagnosis but was reported to develop
later in life in some individuals. In addition, kyphosco-
liosis represents a clinical feature of EDS type VIA with
a high frequency of inter- and intrafamilial variability
regarding severity and age of onset with no obvious
association to the PLOD1 gene genotype. Age of onset
of kyphoscoliosis might indirectly be of importance for
progress or delay of motor developmental milestones
and thus might reflect a prognostic factor for achieve-
ment of ambulation. In addition, but of utmost impor-
tance a less severe clinical phenotype seems to exist,
only presenting in adulthood with acute life threatening
vascular events and velvety skin, without skeletal invol-
vement. Clinical data of additional patients is required
to validate our findings and to investigate possible fac-
tors contributing to inter- and intrafamilial variability.
Conclusion
In conclusion EDS VIA, the kyphoscoliotic type of EDS
is a rare disease which should be considered in any indi-
vidual presenting with muscular hypotonia, progressive
kyphoscoliosis or antenatal vascular event of unknown
origin. Determination of urinary pyridinoline cross-links
is a fast, non-invasive, simple, and indeed reliable diag-
nostic test, which might improve diagnosis of a yet
under diagnosed disease.
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